Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Linezolid in VAP by MRSA: a better choice?

× No keyword cloud information.

32 in total

1. Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin.

Authors: J Ariza; M Pujol; J Cabo; C Peña; N Fernández; J Liñares; J Ayats; F Gudiol
Journal: Lancet Date: 1999-05-08 Impact factor: 79.321

2. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia.

Authors: H Dupont; H Mentec; J P Sollet; G Bleichner
Journal: Intensive Care Med Date: 2001-02 Impact factor: 17.440

3. The activity of vancomycin against heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus explored using an in vitro pharmacokinetic model.

Authors: J Turner; R A Howe; M Wootton; K E Bowker; H A Holt; V Salisbury; P M Bennett; T R Walsh; A P MacGowan
Journal: J Antimicrob Chemother Date: 2001-11 Impact factor: 5.790

Review 4. Ventilator-associated pneumonia.

Authors: Jean Chastre; Jean-Yves Fagon
Journal: Am J Respir Crit Care Med Date: 2002-04-01 Impact factor: 21.405

5. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study.

Authors: E Rubinstein; S Cammarata; T Oliphant; R Wunderink
Journal: Clin Infect Dis Date: 2001-01-26 Impact factor: 9.079

6. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.

Authors: M H Kollef; G Sherman; S Ward; V J Fraser
Journal: Chest Date: 1999-02 Impact factor: 9.410

7. Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group.

Authors: J Fagon; H Patrick; D W Haas; A Torres; C Gibert; W G Cheadle; R E Falcone; J D Anholm; F Paganin; T C Fabian; F Lilienthal
Journal: Am J Respir Crit Care Med Date: 2000-03 Impact factor: 21.405

8. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia.

Authors: Richard G Wunderink; Jordi Rello; Sue K Cammarata; Rodney V Croos-Dabrera; Marin H Kollef
Journal: Chest Date: 2003-11 Impact factor: 9.410

9. Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin.

Authors: Marin H Kollef; Jordi Rello; Sue K Cammarata; Rodney V Croos-Dabrera; Richard G Wunderink
Journal: Intensive Care Med Date: 2004-01-09 Impact factor: 17.440

10. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.

Authors: J L Vincent; D J Bihari; P M Suter; H A Bruining; J White; M H Nicolas-Chanoin; M Wolff; R C Spencer; M Hemmer
Journal: JAMA Date: 1995 Aug 23-30 Impact factor: 56.272

3 in total

Review 1. Benefit-risk assessment of linezolid for serious gram-positive bacterial infections.

Authors: Matthew E Falagas; Konstantinos Z Vardakas
Journal: Drug Saf Date: 2008 Impact factor: 5.606

Review 2. Year in review in intensive care medicine, 2004. I. Respiratory failure, infection, and sepsis.

Authors: Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerome Pugin; Michael Pinsky; Peter Radermacher; Christian Richard; Robert Tasker; Benoit Vallet
Journal: Intensive Care Med Date: 2004-12-18 Impact factor: 17.440

Review 3. Recently published papers: bugs, fluids, obesity and food.

Authors: Neil Hall; Gareth Williams
Journal: Crit Care Date: 2004-05-06 Impact factor: 9.097

3 in total